0IV3 Stock Price, Chart, Stats & News

Geron Corporation
Save
900.53M
Market cap
–
Current P/E
–
Forward P/E
0IV3 chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Geron Corporation is an advanced-stage biopharmaceutical company specializing in the creation and market introduction of therapies for myeloid hematologic malignancies. Its principal drug candidate, imetelstat, is a telomerase inhibitor currently undergoing Phase 3 clinical trials. This agent is designed to curb the rampant proliferation of malignant stem and progenitor cells in these blood cancers.
Similar securities
Based on sector and market capitalization
Report issue











